Zhen Lu

Associate Professor

The University of Texas MD Anderson Cancer Center

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2024

Year:

2024

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Robin Parks

Ottawa Hospital Research Institute

CANADA

View details

Hariprasad Vankayalapati

Chief Scientific Officer

UNITED STATES

View details

Barbara C. Vanderhyden

University of Ottawa

CANADA

View details

Hu Chen

Assistant Professor

Baylor College of Medicine

UNITED STATES

View details

Yitao Tang

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Jinsong Liu

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

Cristina Ivan

Assistant Professor RFA

The University of Texas MD Anderson Cancer Center

UNITED STATES

View details

YONGSANG SONG

Professor

Seoul National University Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Zhen Lu

Research Interests

Explore related searches

Contact this professor

Articles (9)

Crizotinib Enhances PARP Inhibitor Efficacy in Ovarian Cancer Cells and Xenograft Models by Inducing Autophagy

DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas

SIK2 inhibition enhances PARP inhibitor activity synergistically in ovarian and triple-negative breast cancers

Nuclear HKII–P-p53 (Ser15) Interaction is a Prognostic Biomarker for Chemoresponsiveness and Glycolytic Regulation in Epithelial Ovarian Cancer

A MYC-Driven Plasma Polyamine Signature for Early Detection of Ovarian Cancer

A Novel Salt Inducible Kinase 2 Inhibitor, ARN-3261, Sensitizes Ovarian Cancer Cell Lines and Xenografts to Carboplatin

Human epididymis protein 4 antigen-autoantibody complexes complement cancer antigen 125 for detecting early-stage ovarian cancer

Poly(adenosine diphosphate ribose) polymerase inhibitors induce autophagy-mediated drug resistance in ovarian cancer cells, xenografts, and patient-derived xenograft models

Proteome profiling uncovers an autoimmune response signature that reflects ovarian cancer pathogenesis

Collaborators (8)

Robin Parks

Hariprasad Vankayalapati

Barbara C. Vanderhyden

Hu Chen

Yitao Tang

Jinsong Liu

Cristina Ivan

YONGSANG SONG

Make your next move.